PINL:GRPOF - Post by User
Post by
PurpleChipson Feb 13, 2020 10:53am
218 Views
Post# 30685830
TBP Enters Into Manufacturing Agreement W/Vitiprints
TBP Enters Into Manufacturing Agreement W/Vitiprints“The previous technology used for the manufacturing process was excellent but unfortunately it was limited by its maximal batch size capacity.” said Dr. Guy Chamberland, Tetra Bio-Pharma’s CEO and Chief Regulatory Officer. “In a first phase of implementation, Tetra’s production capacity will increase from 2,500 dosing capsules in a 3-day shift to 100,000 CAUMZ™ dosage units in a single 8-hour shift. The second phase will involve a scale-up and transfer of this proprietary technology to a Greater Montreal Pharmaceutical facility.” https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2020/Tetra-Bio-Pharma-Enters-into-Manufacturing-Agreement-with-Vitiprints-LLC-for-CAUMZ-and-HCC011/default.aspx